Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_assertion type Assertion NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_head.
- NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_assertion description "[Direct sequencing analyses were performed in 19 genes, including ALS/frontotemporal lobar degeneration (FTLD)-related genes (SOD2, SOD3, ALS2/alsin, SMN1, PGRN, ANG, VEGF, VCP, VAPB, DCTN1, CHMP2B, and TARDBP or TDP-43), tauopathy-related gene (GSK3beta), and parkinsonism-related genes (alpha-synuclein, LRRK2, parkin, DJ-1, PINK1, and ATP13A2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_provenance.
- NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_assertion evidence source_evidence_literature NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_provenance.
- NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_assertion SIO_000772 18759352 NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_provenance.
- NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_assertion wasDerivedFrom befree-2016 NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_provenance.
- NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_assertion wasGeneratedBy ECO_0000203 NP690761.RACT9o_to1b0f6iNsm-5laRi8e4WyAoejUqiul1xpDzJY130_provenance.